Attenuation of High-fat Diet Induced body Weight Gain, Adiposity and Biochemical Anomalies After Chronic Administration of Ginger {zingiber officinale) in Wistar Rats

International Journal of Pharmacology

Volumn 7, Issue 8, 2011, Pages 801-812

  Malik, Z A ^a   Sharmaa, P L ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Adipose tissue; Ginger; High fat diet; Obesity; Thennogenesis

Indexed keywords

ALKALOID DERIVATIVE; ASCORBIC ACID; CAROTENOID; FLAVANOID; GINGER EXTRACT; GLYCOSIDE; PHENOL; PROPRANOLOL; SAPONIN DERIVATIVE; SIBUTRAMINE; STEROID; TANNIN DERIVATIVE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; CORE TEMPERATURE; DIET RESTRICTION; DRUG EFFICACY; DRUG MECHANISM; FAT CONTENT; FECES ANALYSIS; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; LIPID DIET; LIVER FUNCTION; LOW DRUG DOSE; MALE; NONHUMAN; OBESITY; PHYTOCHEMISTRY; PREVENTION STUDY; RAT; THERMOGENESIS; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT GAIN;

EID: 84255162256     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2011.801.812     Document Type: Article

References (56)

1. Afoakwah, A.N. and W.B. Owusu, 2011. The relationship between dietary intake, body composition and blood pressure in male adult miners in Ghana. Asian J. Clin. Nutr., 3: 1-13.
2. Afndi, A.K., M. Safdar, M.M.A.K. Khattak and A. Khan, 2003. Health risks of overweight and obesity: An overview. Pak. J. Nutr., 2: 350-360.
3. Afzal, M., D. Al-Hadidi, M. Menon, J. Pesek and M. Dhami, 2001. Ginger: An ethnomedical, chemical and pharmacological review. Drug Metab. Drug Interact, 18: 159-190.
4. Al-Amin, Z.M., M. Thomson, K.K. Al-Qattan, R. Peltonen-Shalaby and M. Ali, 2006. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br. J. Nutr., 96: 660-666.
5. Al-Attar, A.M. and T.A. Zari, 2007. Modulatory effects of ginger and clove oils on physiological responses in streptozotocin-induced diabetic rats. Int. J. Pharmacol, 3: 34-40.
6. AH, B.H., G. Blunden, M.O. Tanira and A. Nemmar, 2008. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food Chem. Toxicol., 46: 409-420.
7. Awang, D.V.C., 1992. Ginger. Can. Pharm. J., 125: 309-311.
8. Bergman, R.N., S.P. Kim, I.R. Hsu, K.J. Calalano and J.D. Chiuetal, 2007. Abdominal obesity: Role in the pathophysiology of metabolic disease and cardiovascular risk. Am. J. Med., 120: S3-S8.
9. Bernardis, L.L. and B.D. Patterson, 1968. Correlation between Lee index and carcass fat content in weanling and adult female rats with hypothalamic lesions. J. Endocrino., 40: 527-528.
10. Bhandari, U., J.N. Sharma and R. Zafar, 1998. The protective action of ethanolic ginger (Zingiber oficinale) extract in cholesterol fed rabbits. J. Ethnopharmacol., 61: 167-171.
11. Brown, M., C. Bing, P. King, L. Pickavance, D. Heal and J. Wilding, 2001. Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y. Br. J. Pharmacol., 132: 1898-1904.
12. Connoley, LP., Y.L. Liu, I. Frost, IP. Reckless, D.J. Heal and M.J. Stock, 1999. Thermogenic effects of sibutramine and its metabolites. Br. J. Pharmacol., 126: 1487-1495.
13. Despres, J.P., I. Lemieux and N. Almeras, 2006. Contribution of CB1 blockade to the management of high-risk abdominal obesity. Int. J. Obes., 30: S44-S52.
14. Dreon, D.M., B. Frey-Hewitt, N. Ellsworth, P.T. Williams, R.B. Terry and P.D. Wood, 1988. Dietary fat: Carbohydrate ratio and obesity in middle-aged men. Am. J. Clin. Nutr., 47: 995-1000.
15. Ebrahimi-Mameghani, M., M. Saghafi-Asl, S. Arefhosseini and M. Khoshbaten, 2008. Is there any association between overweight, obesity and symptoms of reflux disease?. Pak. J. Biol. Sci., 11: 443-447.
16. Eldershaw, T.P., E.Q. Colquhoun, K.A. Dora, Z.C. Peng and M.G. Clark, 1992. Pungent principles of ginger (Zingiber officinale) are thermogenic in the perfused rat hindlimb. Int. J. Obes. Relat. Metab. Disord., 16: 755-763.
17. Franssila-Kallunki, A., A. Rissanen, A. Ekstrand, A. Ollus and L. Groop, 1992. Weight loss by very-low-calorie diets: Effects on substrate oxidation, energy expenditure and insulin sensitivity in obese subjects. Am. J. Clin Nutr., 56: 247S-248S.
18. Fuhrman, B., M. Rosenblat, T. Hayek, R. Coleman and M. Aviram, 2000. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J. Nutr., 130: 1124-1131.
19. Fujisawa, F., T. Nadamoto and T. Fushiki, 2005. Effect of intake of ginger on peripheral body temperature. J. Jpn Soc. Nutr. Food Sci., 58: 3-9.
20. Goyal, R.K. and S.V. Kadnur, 2006. Beneficial effects of Zingiber officinale on gold thioglucose induced obesity. Fitoterapia, 77: 160-163.
21. Greenway, F.L., E. Dunayevich, G. Tollefson, J. Erickson and M. Guttadauria et al., 2009. Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo. J. Clin. Endocrinol. Metabol, 94: 4898-4906.
22. Hameed, A., S.A. Malik, F. Rabbi, A. Sharif and N. Ahmad et al., 2002. Diabetic complications: Influence of age, sex, family history, duration, glycemic control and obesity. J. Biol. Sci., 2: 710-714.
23. Han, L.K., X.J. Gong, S. Kawano, M. Saito, Y. Kimura and H. Okuda, 2005. Antiobesity actions of Zingiber officinale Roscoe. YakugakuZasshi, 125: 213-217.
24. Harrold, J.A., P.S. Widdowson, J.C. Clapham and G. Williams, 2000. Individual severity of dietary obesity in unselected wistar rats: Relationship with hyperphagia. Am. J. Physiol. Endocrinol. Metab., 279: E340-E347.
25. Ioannides-Demos, L.L., J. Proietto, A.M. Tonkin and J.J. McNeil, 2006. Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf, 29: 277-302.
26. Iwasaki, Y., A. Morita, I. Iwasawa, K. Kobataand, Y. Sekiwa et al., 2006. A nonpungent component of steamed ginger-[l 0]-shogaol-increases adrenaline secretion via activation of TRPVI. Nutr. Neurosci., 96: 169-178.
27. Klein, B.P. and A.K. Perry, 1982. Ascorbic acid and vitamin A activity in selected vegetables from different geographical areas of the United States. J. Food Sci., 47: 941-945.
28. Lewington, S., G. Whitlock, R. Clarke, P. Sherliker and J. Emberson et al., 2007. Blood cholesterol and vascular mortality by age, sex and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet, 370: 1829-1839.
29. Litchfield, J.T. and F. Wilcoxon, 1949. Asimplifiedmethod of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther.,96: 99-113.
30. Malik, Z.A., A. Goyalandm, P.L. Sharma, 2011a. Mustard oil based high fat diet is associated with decreased body weight gain, less adiposity and improved glucose and lipid homeostasis in wistar rats. Asian J. Clin. Nutr., 3: 43-52.
31. Malik, Z.A., M. Singh and P.L. Sharma, 2011b. Neuroprotective effect of Momordica charantia in global cerebral ischemia and reperfusion induced neuronal damage in diabetic mice. J. EthnopharmacoL, 133: 729-734.
32. Mantha, L., E. Palacios and Y. Deshaies, 1999. Modulation of triglyceride metabolism by glucocorticoids in diet-induced obesity. Am. J. Physiol, 277: R455-R464.
33. Nammi, S., S. Sreemantula and B.D. Roufogalis, 2009. Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic Clin. Pharmacol. Toxicol., 104: 366-373.
34. Neess, G.C., Z. Zhao and D. Lopez, 1996. Inhibitor of cholesterol biosynthesis increase hepatic low density lipoprotein degradation. Arch. Biochem. Biophys., 325: 242-248.
35. Nguyen, D.M. and H.B. El-Serag, 2010. The epidemiology of obesity. Gastroenterol. Clin. North Am., 39: 1-7.
36. Nicoll, R. and M.Y. Henein, 2009. Ginger (Zingiber officinale Roscoe): A hot remedy for cardiovascular disease? Int. J. Cardiol, 131: 408-409.
37. Oakes, N.D., G.J. Cooney, S. Camilleri, D.J. Chisholm and E.W. Kraegen, 1997. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes, 46: 1768-1774.
38. Pulbutr, P., K. Thunchomnang, K. Lawa, A. Mangkhalathon and P. Saenubol, 2011. Lipolytic effects of zingerone in adipocytes isolated from normal diet-fed rats and high fat diet-fed rats. Int. J. Pharmacol, 7: 629-634.
39. Ranganna, S., 1986. Handbook of Analysis and Quality Control for Fruit and Vegetable Products. 2nd Edn, McGraw-Hill Publishing Co. Ltd., New Delhi Pages: 1112.
40. Rolls, B.J. and V.A. Hammer, 1995. Fat, carbohydrate and the regulation of energy intake. Am. J. Clin. Nutr., 62: 1086S-1095S.
41. 1 treatmental effects]. Pak. J. Nutr., 5: 373-376.
42. Sharpe, P.A., M.L. Granner, J.M. Conway, B.E. Ainsworth and M. Dobre, 2006. Availability of weight-loss supplements: Results of an audit of retail outlets in a Southeastern city. J. Am. Diet Assoc, 106: 2045-2051.
43. Singleton, V.L. and J. A. Rossi, 1965. Colorimetric of total phenolics with phosphomolybdic-phosphotungstic acid reagent. Am. J. Enol Viticult, 16: 144-158.
44. Sivakumar, V. and S. Sivakumar, 2004. Effect of an indigenous herbal compound preparation Trikatu on the lipid profiles of atherogenic diet and standard diet fedRattus norvegicus. Phytother. Res., 18: 976-981.
45. Srinivasan, K. and K. Sambaiah, 1991. The effect of spices on cholesterol 7 alpha-hydroxylase activity and on serum and hepatic cholesterol levels in the rat. Int. J. Vitam. Nutr. Res., 61: 364-369.
46. St-Piene, J., I. Lemieux, P. Penon, D. Brisson, M. Santure, M. Vohl, J. Despres and D. Gaudet, 2007. Relation of the hypertriglyceridemic Waist phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am. J. Cardiol, 99: 369-373.
47. Tannenbaum, B.M., D.N. Brindley, G.S. Tannenbaum, M.F. Dallman, M.D. McArthur and M.J. Meaney, 1997. High-fat feeding alters both basal and stress-induced hypothalamic-pituitary-adrenal activity in the rat. Am. J. Physiol, 273: E1168-E1177.
48. Tapsell, L.C., I. Hemphill, L. Cobiac, C.S. Patch and D.R. Sullivan et al., 2006. Health benefits of herbs and spices: The past, the present, the future. Med. J. Aust, 185: S4-S24.
49. Trease, G.E. and W.C. Evans, 1989. Pharmacognosy. 13th Edn., Bailliere Tindall, London.
50. Wadden, T.A., M.L. Butrynand, K.J. Byrne, 2004. Efficacy of lifestyle modification for long-term weight control. Obes. Res., 12: 151S-162S.
51. Webber, J. and LA. Macdonald, 2000. Signalling in body-weight homeostasis: Neuroendocrine efferent signals. Proc. Nutr. Soc, 59: 397-404.
52. Weyer, C, J.F. Gautier and E. Danforth, 1999. Development of a 3-adrenoceptor agonists for the treatment of obesity and diabetes-an update. Diabetes Metab., 25: 11 -21.
53. Weyer, C, R.L. Walford, IT. Harper, M. Milner, T. MacCallum, P. A. Tataranm and E. Ravussin, 2000. Energy metabolism after 2 y of energy restriction: The Biosphere 2 experiment. Am. J. Clin. Nutr., 72: 946-953.
54. Wilding, J.P., S.G. Gilbey, M. Mannan, N. Aslam, M.A. Ghatei and S.R. Bloom, 1992. Increased neuropeptide Y content in individual hypothalamic nuclei but not neuropeptide Y inRNA, in diet-induced obesity in rats. J. Endocrinol., 132: 299-304.
55. York, D.A., S. Thomas, F.L. Greenway, Z. Liu and J.C. Rood, 2007. Effect of an herbal extract Number Ten (NT) on body weight in rats. Chin. Med., 2: 10-10.
56. Zou, Y., Y. Lu and D. Wei, 2004. Antioxidant activity of a flavonoid-rich extract of Hypericum perforatum L. J. Agnc. FoodChem., 50: 5032-5039.